Ahmed Elsayyad

Bio:

Co-founder and President of Ostro (acquired by Veeva, NYSE: VEEV in 2026), an AI company partnered with most of the top 20 pharma companies as well as many mid-size pharma and smaller biotechs.

After studying medicine at the Icahn School of Medicine at Mount Sinai and earning a degree in Public Health, Bioethics, and Philosophy from Johns Hopkins University, Ahmed left academia to launch Ostro with the goal of modernizing pharmaceutical marketing through personalized, compliant, and scalable digital experiences. Today, the majority of the top 20 pharmaceutical companies leverage Ostro to improve engagement with doctors and patients through real-time personalization and omnichannel activation. A Forbes 30 Under 30 honoree in Healthcare, Ahmed is recognized for bridging clinical insight, technology, and strategy to help brands deliver better access, outcomes, and patient support.